Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingebrigt Sylte

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry|November 5, 2011
Synthesis, molecular modeling studies and biological evaluation of fluorine substituted analogs of GW 501516Calin C Ciocoiu, Aina W Ravna, Ingebrigt Sylte, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 5, 2002
[New techniques for optimization of thiopurine therapy in leukemia and transplantation]Thrina Loennechen, Roy Andre Lysaa, Trude Giverhaug, et al.
Plos One|December 25, 2013
A linear combination of pharmacophore hypotheses as a new tool in search of new active compounds--an application for 5-HT1A receptor ligandsDawid Warszycki, Stefan Mordalski, Kurt Kristiansen, et al.
Pharmacology Research & Perspectives|June 6, 2019
Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modelingMarthe F Fjelldal, Thibaud Freyd, Linn M Evenseth, et al.
Theoretical Biology & Medical Modelling|September 17, 2013
Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)Inger Lindin, Yimingjiang Wuxiuer, Irina Kufareva, et al.
Biochemical Pharmacology|May 28, 2004
Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT(1A) receptorsAnna Agnieszka Strzelczyk, Malgorzata Jarończyk, Zdzislaw Chilmonczyk, et al.
Current Topics in Medicinal Chemistry|October 4, 2012
Dipeptide inhibitors of thermolysin and angiotensin I-converting enzymeMahmud Tareq Hassan Khan, Kenichi Dedachi, Toshiro Matsui, et al.
Bioorganic & Medicinal Chemistry|September 25, 2008
The molecular interactions of buspirone analogues with the serotonin transporterMałgorzata Jarończyk, Zdzisław Chilmonczyk, Aleksander P Mazurek, et al.
Bioorganic & Medicinal Chemistry|February 25, 2005
Conformational restrictions in ligand binding to the human intestinal di-/tripeptide transporter: implications for design of hPEPT1 targeted prodrugsJon Våbenø, Carsten Uhd Nielsen, Bente Steffansen, et al.
Journal of Molecular Graphics & Modelling|November 25, 2011
Specific interactions and binding energies between thermolysin and potent inhibitors: molecular simulations based on ab initio molecular orbital methodTatsuya Hirakawa, Seiya Fujita, Tatsuya Ohyama, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry|November 5, 2011
Synthesis, molecular modeling studies and biological evaluation of fluorine substituted analogs of GW 501516Calin C Ciocoiu, Aina W Ravna, Ingebrigt Sylte, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 5, 2002
[New techniques for optimization of thiopurine therapy in leukemia and transplantation]Thrina Loennechen, Roy Andre Lysaa, Trude Giverhaug, et al.
Plos One|December 25, 2013
A linear combination of pharmacophore hypotheses as a new tool in search of new active compounds--an application for 5-HT1A receptor ligandsDawid Warszycki, Stefan Mordalski, Kurt Kristiansen, et al.
Pharmacology Research & Perspectives|June 6, 2019
Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modelingMarthe F Fjelldal, Thibaud Freyd, Linn M Evenseth, et al.
Theoretical Biology & Medical Modelling|September 17, 2013
Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)Inger Lindin, Yimingjiang Wuxiuer, Irina Kufareva, et al.
Biochemical Pharmacology|May 28, 2004
Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT(1A) receptorsAnna Agnieszka Strzelczyk, Malgorzata Jarończyk, Zdzislaw Chilmonczyk, et al.
Current Topics in Medicinal Chemistry|October 4, 2012
Dipeptide inhibitors of thermolysin and angiotensin I-converting enzymeMahmud Tareq Hassan Khan, Kenichi Dedachi, Toshiro Matsui, et al.
Bioorganic & Medicinal Chemistry|September 25, 2008
The molecular interactions of buspirone analogues with the serotonin transporterMałgorzata Jarończyk, Zdzisław Chilmonczyk, Aleksander P Mazurek, et al.
Bioorganic & Medicinal Chemistry|February 25, 2005
Conformational restrictions in ligand binding to the human intestinal di-/tripeptide transporter: implications for design of hPEPT1 targeted prodrugsJon Våbenø, Carsten Uhd Nielsen, Bente Steffansen, et al.
Journal of Molecular Graphics & Modelling|November 25, 2011
Specific interactions and binding energies between thermolysin and potent inhibitors: molecular simulations based on ab initio molecular orbital methodTatsuya Hirakawa, Seiya Fujita, Tatsuya Ohyama, et al.
Pageof 10